Susquehanna analyst issues POSITIVE recommendation for CHRW on March 26, 2025 11:29AM ET. The previous analyst recommendation was Positive.CHRW was trading at $101.66 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues OUTPERFORM recommendation for AEP on March 26, 2025 11:31AM ET. The previous analyst recommendation was Outperform.AEP was trading at $103.695 at issue of the analyst recommendation.The...
Susquehanna analyst issues NEUTRAL recommendation for SNDR on March 26, 2025 11:30AM ET. The previous analyst recommendation was Neutral.SNDR was trading at $23.3 at issue of the analyst recommendation.The overall...
Guggenheim analyst issues BUY recommendation for IFRX on March 26, 2025 11:00AM ET. The previous analyst recommendation was Buy.IFRX was trading at $1.27 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues NEUTRAL recommendation for JBHT on March 26, 2025 11:07AM ET. The previous analyst recommendation was Positive.JBHT was trading at $150.42 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues POSITIVE recommendation for KNX on March 26, 2025 11:29AM ET. The previous analyst recommendation was Positive.KNX was trading at $44.38 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues UNDERWEIGHT recommendation for APA on March 26, 2025 11:55AM ET. The previous analyst recommendation was Underweight.APA was trading at $21.19 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues CAUTIOUS recommendation for MTDR on March 26, 2025 11:59AM ET. The previous analyst recommendation was Cautious.MTDR was trading at $53.03 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for CRVS on March 26, 2025 11:44AM ET. The previous analyst recommendation was Outperform.CRVS was trading at $3.365 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CVE on March 26, 2025 11:56AM ET. The previous analyst recommendation was Overweight.CVE was trading at $14.385 at issue of the analyst recommendation.The...
